0.00795
price down icon32.63%   -0.00385
 
loading

Finanzdaten der Petros Pharmaceuticals Inc-Aktie (PTPI)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31
Periodenlänge 3 Monate
Revenues
Cost Of Revenue
Gross Profit
Operating Expenses
Benefits Costs and Expenses
Costs And Expenses
Provision For Loan, Lease, And Other Losses
Operating Income/Loss
Net Interest Income/Expense
Interest Income/Expense After Provision For Losses
Income/Loss From Continuing Operations Before Tax
Income/Loss From Continuing Operations After Tax
Net Income/Loss
Preferred Stock Dividends And Other Adjustments
Attributable To Noncontrolling Interest
Basic Average Shares
Diluted Average Shares
Basic Earnings Per Share
Diluted Earnings Per Share
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
drug_manufacturers_specialty_generic RGC
$21.00
price down icon 8.30%
$22.63
price down icon 0.57%
drug_manufacturers_specialty_generic RDY
$14.04
price down icon 0.14%
$141.83
price up icon 0.62%
$12.45
price down icon 0.72%
$487.25
price down icon 1.80%
Kapitalisierung:     |  Volumen (24h):